Navigation Links
Basic work on E. coli identifies two new keys to regulation of bacterial gene expression

The cellular process of transcription, in which the enzyme RNA polymerase constructs chains of RNA from information contained in DNA, depends upon previously underappreciated sections of both the DNA promoter region and RNA polymerase, according to work done with the bacterium E. coli and published today (June 16) in the journal Cell by a team of bacteriologists from the University of Wisconsin-Madison.

This fundamental research about a key step in RNA synthesis has important implications for the study of gene expression in other organisms, and adds to the wealth of knowledge about E. coli contributed by scientists from the UW-Madison.

"The kinds of processes that we study in E. coli happen in a wide variety of bacteria of medical, environmental and agricultural importance," notes Rick Gourse, a professor of bacteriology who published the Cell paper along with a team from his lab. "This knowledge can ultimately be put to use in systems that aren't so amenable to investigation, such as bacteria that cause cholera, produce anthrax toxin or lead to ulcers and stomach cancer."

Scientists use model organisms because they are relatively easy to work with and because there is a vast amount of previous knowledge about them. They can then test whether their findings in model organisms hold true in other species, says Gourse, who studies a strain of E. coli that while harmless, is closely related to disease-causing varieties like E. coli 0157:H7.

"Basic research in E. coli is very important," says Gourse. "Much of what we know about gene expression both in bacteria and in higher life forms comes from work performed originally on this model organism." The strain that Gourse works with is one of the most well-studied species in biology and has important ties to the UW-Madison.

In his most recent study, Gourse investigated the interaction between RNA polymerase and promoters from the E. coli chromosome. RNA polymerase reads the informat ion in DNA and transcribes it into chains of RNA, which are later translated into proteins. Promoter regions are specific sequences within the DNA chain that tell RNA polymerase when and where to begin transcription, and how much product to make from specific genes.

Gourse's group found that there is a specific region within DNA promoters that makes contact with a highly conserved but previously underappreciated segment of the sigma subunit of RNA polymerase. While the contact with sigma is very strong at promoters for most genes, it is particularly weak at promoters that make ribosomal RNA, which means that other factors like nutritional and environmental signals ultimately regulate the expression of those genes.

"In this case, regulation is achieved not because the promoter makes a special contact, but because it can't establish contact at all," says Gourse. "This is an example of how sometimes less is more, and a probably very ancient example of one of the methods that arose through evolution to regulate gene expression."

Ribosomal RNA makes up the bulk of ribosomes, the molecular machines that make proteins and are present in huge numbers in all cells. Since so much of the cell's energy is used to make ribosomes, control of ribosomal RNA transcription is particularly crucial to a cell's well-being.

"This work is basic to the growth of all bacteria," says Gourse. "By understanding transcription and control of ribosome synthesis in E. coli, we can understand more about these processes in bacterial species that we need to control, like those that cause disease or make toxins. E. coli is also the workhorse of the biotechnology industry. Understanding E. coli gene expression in detail allows us to harness these cells for producing products of biotechnological importance, like pharmaceuticals."

Gourse's work was supported by the National Institutes of Health, the United States Department of Agriculture, and by Pfizer Biotechno logy. His team included graduate student Shanil Haugen; undergraduate Christopher Ward; and senior scientists Wilma Ross and Tamas Gaal.


Source:University of Wisconsin-Madison

Related biology news :

1. Distributed Basic Local Alignment Search Toolkit (W.ND-BLAST)
2. Basic research leads to a novel cancer therapy
3. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
4. New lab technique identifies high levels of pathogens in therapy pool
5. Study identifies gene in mice that may control risk-taking behavior in humans
6. Researcher at UGA College of Veterinary Medicine identifies new way of combating viral diseases
7. U. of Colorado researcher identifies tracks of swimming dinosaur in Wyoming
8. Model identifies genes that induce normal skin cells to become abnormal
9. New study identifies key gene in development of connections between brain and spinal cord
10. New HIV study identifies high-risk subgroups of adolescents
11. Research identifies protein in mice that regulates bone formation
Post Your Comments:

(Date:10/12/2015)... 9, 2015 Research and Markets ( ... new report "Biometrics: Market Shares, Strategies, and Forecasts, ... --> --> The study is ... market segment. Research represents a selection from the mountains ... market materials, with selections made by the most senior ...
(Date:10/8/2015)... Calif. , Oct. 8, 2015 ... of human interface solutions, announced today that it ... of fiscal 2016 on Thursday, October 22, 2015, ... host a corresponding conference call for analysts and ... during which management may discuss forward-looking information.    ...
(Date:10/6/2015)... , Oct. 6, 2015 Track Group, Inc. ... that it has signed a contract with the Virginia ... the full range of sentences under the Department,s oversight. ... the Americas. "This contract with the Virginia DOC will ... US and advances our position as a trusted leader ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... SPRINGS, Florida , October 13, 2015 ... AVXLD), Juno Therapeutics, Inc. (NASDAQ: JUNO ), and ... ARRY ), Avanex Life Sciences Corp. (OTCQX: AVXLD), ... Pharmaceuticals, Inc. (NASDAQ: PGNX ) --> ... and the biotech industry can potentially lead to advancements ...
(Date:10/13/2015)... 13, 2015  According to Kalorama Information, the ... $102 billion by the end of 2015. Clinical ... industry, as it is estimated that approximately 80% ... tests. In addition to diagnosing patients, clinical lab ... progression, monitor drug treatment and conditions, and determine ...
(Date:10/13/2015)... ... ... Proove Biosciences, a commercial and research leader ... Medicine of the University of Southern California (USC) Pain Center to study ... Clinical Objectives Linking Genotypic and Phenotypic Association with Pain Outcomes) is one of ...
(Date:10/12/2015)... 2015  MiMedx Group, Inc. (NASDAQ: MDXG ), ... and patent-protected processes to develop and market advanced products ... Sports Medicine, Ophthalmic, and the Dental sectors of healthcare, ... filed against the Company has been dismissed by the ... and CEO, stated, "As we suspected, this case was ...
Breaking Biology Technology: